CAM-H2 effectively targets and treats HER2 positive brain lesions: A comparative preclinical study with trastuzumab

J. Puttemans, M. D'Huyvetter, B. Windhorst, T. Lahoutte, N. Devoogdt

Research output: Contribution to journalMeeting abstract (Journal)

Original languageEnglish
JournalAnnals of Oncology
Volume30
Publication statusPublished - May 2019

Cite this